Oragenics, Inc.
Oragenics, Inc. (OGEN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ogen · stock forecast · 3 analysts (3M) · FMP · updated Jun 1, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Hold
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.60
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.61 | ↑ 1.16% |
1-day model range: $0.6–$0.62. Peak: $0.62 (+1.16%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · OGEN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-06-03 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2020-04-16 | H.C. Wainwright | Downgrade ↓ | Buy→Neutral |
| 2019-11-15 | UBS | Maintains | Neutral→Neutral |
| 2019-04-26 | H.C. Wainwright | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Oragenics, Inc. (OGEN) stock. Of the recent 4 rating actions, 0 were upgrades and 1 were downgrades. 3 analysts currently cover OGEN.
Analyst Recommendation Trends
OGEN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-0.76
EPS Next Year
$-0.69
↓ 9.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast OGEN EPS of $-0.76 for the current fiscal year, based on estimates from 1 analysts. The OGEN revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The OGEN stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OGEN price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The OGEN short-term stock prediction for tomorrow is $0.61 (+1.16%).
Oragenics, Inc. trades on AMEX under the ticker OGEN. The OGEN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
OGEN forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month OGEN price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.60.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.